Literature DB >> 22088477

Comprehensive investigation of the influence of acidic, basic, and organic mobile phase compositions on bioanalytical assay sensitivity in positive ESI mode LC/MS/MS.

Paul D Rainville1, Norman W Smith, David Cowan, Robert S Plumb.   

Abstract

The sensitivity and accuracy of a bioanalytical method is critical in defining the pharmacokinetic (PK) parameters of a potential new chemical entity (NCE). Inhaled therapeutics and low dose NCEs present one of the most significant analytical challenges to the bioanalyst, due to their low systemic concentration. The sensitivity of a bioanalytical LC/MS/MS based assay can be influenced by multiple parameters, including: mobile phase composition, extraction efficiency and chromatographic performance. In this work, we discuss the influence of acidic (pH 3), and basic (pH 10) aqueous mobile phases in conjunction with the two most common organic modifiers used in HPLC, acetonitrile and methanol, on the assay sensitivity of twenty-four probe pharmaceuticals in solvent and biological fluid extract. The study showed that when the test probe pharmaceuticals were analyzed with basic aqueous mobile phases compared to standard acidic conditions the following results were observed: increases in chromatographic peak area ranging from 1.2 to 9.6 fold for twenty-one of the test compounds as well as increased signal-to-noise for greater than seventy percent of the compounds. This observed increase in the MS response was not necessarily related to the later elution of the analyte in a higher organic composition under basic conditions. This was demonstrated as seven out of the twenty-four (approximately thirty percent) of the probe pharmaceuticals tested, eluted earlier, or with the same retention time, under basic conditions, and still produced a greater signal-to-noise when analyzed under these basic conditions. Also observed were decreases in chromatographic peak width, and increases in the retention time of very hydrophilic pharmaceutical compounds. The effect of the mobile phase combinations on the retention and MS response of the choline-containing phospholipids present in precipitated plasma was also investigated, as these analytes are a major source of interference when developing a bioanalytical assay. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22088477     DOI: 10.1016/j.jpba.2011.10.021

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  5 in total

Review 1.  Recent developments and emerging trends of mass spectrometric methods in plant hormone analysis: a review.

Authors:  Liyuan Wang; Yilin Zou; Han Yeong Kaw; Gang Wang; Huaze Sun; Long Cai; Chengyu Li; Long-Yue Meng; Donghao Li
Journal:  Plant Methods       Date:  2020-04-16       Impact factor: 4.993

Review 2.  Detection and quantification of Covid-19 antiviral drugs in biological fluids and tissues.

Authors:  Maria A Acquavia; Luca Foti; Raffaella Pascale; Antonia Nicolò; Vincenzo Brancaleone; Tommaso R I Cataldi; Giuseppe Martelli; Laura Scrano; Giuliana Bianco
Journal:  Talanta       Date:  2020-11-05       Impact factor: 6.057

3.  Sensitive Quantification of Liensinine Alkaloid Using a HPLC-MS/MS Method and Its Application in Microvolume Rat Plasma.

Authors:  Fen Wei; Xilan Gou; Xiao Xu; Sicen Wang; Tao Bao
Journal:  J Anal Methods Chem       Date:  2021-02-26       Impact factor: 2.193

4.  Lactoferrin Supplementation during Gestation and Lactation Is Efficient for Boosting Rat Pup Development.

Authors:  Anne Blais; Annaïg Lan; Alice Boluktas; Marta Grauso-Culetto; Catherine Chaumontet; François Blachier; Anne-Marie Davila
Journal:  Nutrients       Date:  2022-07-08       Impact factor: 6.706

5.  Validation of a LC-MS/MS method for quantifying urinary nicotine, six nicotine metabolites and the minor tobacco alkaloids--anatabine and anabasine--in smokers' urine.

Authors:  James E McGuffey; Binnian Wei; John T Bernert; John C Morrow; Baoyun Xia; Lanqing Wang; Benjamin C Blount
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.